Anna Kostareva

Dr. Anna Kostareva is a Professor at the Almazov National Medical Research Centre in St. Petersburg, Russia, affiliated with the Institute of Molecular Medicine and Department of Molecular Cardiology and Genetics. She has established herself as a leading researcher in cardiovascular genetics, with particular expertise in cardiomyopathies, skeletal muscle biology, and molecular mechanisms of heart disease.

Her educational background, while not explicitly detailed in the provided materials, appears to be rooted in molecular biology and cardiology, likely with advanced degrees from Russian institutions given her long-standing research presence in the Russian medical research community. Her collaborations with prominent Russian researchers like Evgeny Shlyakhto suggest deep integration within Russia's cardiovascular research ecosystem.

Dr. Kostareva's research interests span Cardiovascular Research, Molecular Genetics, Cardiomyopathies, and Skeletal Muscle Biology. Her work demonstrates a consistent focus on the intersection of cardiac and neuromuscular disorders, with particular attention to genetic mechanisms. She has made significant contributions to understanding how genetic variants manifest in cardiac phenotypes, especially in Russian patient populations.

Her publication record shows a clear progression from foundational work on cardiomyopathies with neuromuscular phenotypes (2013) to more recent sophisticated investigations of sodium channelopathies (2024) and genetic variants in rare diseases. The trajectory reveals an expanding research scope that now encompasses skeletal muscle unloading effects, mitochondrial dysfunction, and the Notch signaling pathway's role in cardiovascular diseases.

Dr. Kostareva has contributed to numerous review articles that have helped shape understanding in her field, including significant works on the Notch pathway as a therapeutic target (2019) and valve interstitial cells in heart valve calcification (2017). Her collaborative approach is evident in her extensive co-authorship network across Russian and international institutions.

Her research program appears well-integrated with clinical applications, particularly in characterizing genetic variants in Russian patient populations and exploring potential therapeutic targets. The consistent publication output across nearly a decade demonstrates sustained research productivity and leadership in her specialized areas of cardiovascular genetics and molecular cardiology.